Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul Brown
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
220 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Lewis and Faye Manderson Cancer Center
Tuscaloosa, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- Mercy Cancer Center - Sacramento
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California San Diego
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Stanford Cancer Center South Bay
San Jose, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente Cancer Treatment Center
South San Francisco, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Uchealth Memorial Hospital Central
Colorado Springs, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Saint Vincent'S Medical Center
Bridgeport, Connecticut, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Boca Raton Regional Hospital
Boca Raton, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2015
- Primary completion
- 30 Apr 2018
- Completion
- 26 Aug 2019
- Last update posted
- 23 Apr 2025
- Registered enrollment
- 518
- Registry id
- NCT02360215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.